Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256749 · ClinicalTrials.gov registry record
A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram
A clinical trial of Craniotomy and Transphenoidal Pituitary Resection, sponsored by Loma Linda University.
- Completed
- Registry status
- 31
- Enrollment target
- 1
- Study location
NCT01256749: Completed study of Craniotomy and Transphenoidal Pituitary Resection, sponsored by Loma Linda University.
NCT01256749 is a study of Craniotomy and Transphenoidal Pituitary Resection that has completed, run by Loma Linda University. The registered enrollment target is 31 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256749, a study of Craniotomy and Transphenoidal Pituitary Resection, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The fundamental reason for comparing the ability of the Frontal Sedline TM Electroencephalogram (PSA EEG) to standard Global 12 Lead Electroencephalogram (EEG) for burst suppression detection is to determine if a less expensive, less invasive and possibly more convenient bifrontal EEG monitor can be effective for evaluation of anesthesia-induced intraoperative burst suppression therapy (IBST) for cerebral protection.
Primary Outcome
The primary outcome measure is correlation between 4 channel frontal PSA EEG pattern and standard global 12 lead EEG during IBST.
Conditions Studied
Study Locations (1)
California
- Loma Linda University - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-11 |
What the finished NCT01256749 record still lists
NCT01256749 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 2 conditions, with Craniotomy appearing as the primary indexed condition, and to 0 interventions.
NCT01256749 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01256749 about?
NCT01256749 is a clinical study titled "A Comparative Study of Global 12 Lead Electroencephalogram to Frontal SedlineTM Electroencephalogram". The fundamental reason for comparing the ability of the Frontal Sedline TM Electroencephalogram (PSA EEG) to standard Global 12 Lead Electroencephalogram (EEG) for burst suppression detection is to determine if a less expensive, less invasive and possibly more convenient bifrontal EEG monitor can be...
What is the current status of trial NCT01256749?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2010-12. Estimated completion is 2013-11.
What conditions does trial NCT01256749 study?
This clinical trial studies the following conditions: Craniotomy, Transphenoidal Pituitary Resection.
Who is sponsoring clinical trial NCT01256749?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01256749 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Craniotomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia